Novel antidiabetic agents and lipid profile
Common first-week side effectsnausea, mild gastrointestinal upset, headachetypically resolve within 3 to 7 days as your body adjusts
When medically appropriate, treatment may include FDA-approved medications , such as: Mounjaro (tirzepatide) Zepbound FDA-approved for chronic weight management Ozempic (semaglutide) Wegovy FDA-approved for weight management Physician-supervised semaglutide or tirzepatide-based programs may also be available
doi:10.18632/oncotarget.11168 [2] Cangul IT, Gul NY, Topal A, Yilmaz R
Conjunctivitis (pink eye) is also common
Understanding how to wean off Zepbound without gaining weight involves medical supervision, structured lifestyle modifications, and ongoing monitoring